Nanomedicine for drug delivery in South Africa: a protocol for systematic review

Abstract

BackgroundThe emergence of nanomedicine in the past decade has changed the landscape of disease diagnosis and treatment. Nanomedicine makes use of nanostructures for applications in different fields of medicine, including drug delivery, biosensors, neuro-electronic interfaces, in vivo imaging, and cell-specific molecular interactions. Despite its relative infancy, nanomedicine has generated a significant body of research as evidenced by peer reviewed literature and several patents. This proposed systematic review will focus specifically on drug delivery systems in which nanoparticles are used to enhance the pharmacological and therapeutic properties of drugs. The strength of nanoparticulate drug delivery systems is their ability to alter the pharmacokinetics and bio-distribution of drugs.Globally, the discourse on nanomedicine is dominated by research being done in the developed countries of Europe and in the United States of America. Less attention has been given to the applications of nanomedicine in developing countries, particularly Africa. There is dearth of information on the applications of nanomedicine in terms of drug delivery with particular reference to which diseases are being targeted generally in Africa. The review will describe the specific diseases that are being targeted and the progress being made in South Africa, with a view to determining whether the applications of nanomedicine are being appropriated to address the context-specific challenges in this country or if they mimic what is being done globally.MethodsKeywords related to nanomedicine and drug delivery will be combined to build a search strategy for each of the following databases: PubMed, Cochrane Library (including Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Database of Systematic Reviews, Cochrane Methodology Register), Google Scholar, NHS Health Technology Assessment Database and Web of Science. We will also check reference lists of included studies for other eligible reports and search unpublished data. To ensure that the search is comprehensive, grey literature will be searched extensively. Literature to be included will have nanomedicine in drug delivery as the primary application and report on the specific diseases that are targeted in South Africa. Two authors will independently screen the search output, select studies and extract data; discrepancies will be resolved by consensus and discussion. When no consensus is reached, the third author will be consultedDiscussionThe systematic review will inform the government, policy-makers, investors, health professionals, scientists, and engineers about the applications of nanomedicine in drug delivery. In particular, it will identify the diseases targeted by the application of nanomedicine for drug delivery and the progress being made in South Africa as the disease burden of this country differs from that of developed countries where nanomedicine has been widely used for drug delivery.Systematic review registrationPROSPERO CRD42017057388Electronic supplementary...

Synthesis of Amphiphilic Copolymers of N-Vinyl-2-pyrrolidone and Allyl Glycidyl Ether for Co-Delivery of Doxorubicin and Paclitaxel

“…Amphiphilic copolymers obtained at various VP/AGE ratios in the reaction mixture, dissolved in water, are capable of forming nanosized aggregates as a result of selfassembly (Figure 6). The number-average diameter of the aggregates increases rapidly with incre proportion of AGE in the co-monomer mixture (Figure 6B) according to the linear re sion Equation (5). A decrease in the VP/AGE concentration ratio (Figure 5) leads to a decrease i molecular weight of the hydrophilic block and, probably, its hydrophilicity.…”

“…Although a number of drugs are known to be used used in chemotherapy, their application is complicated by low bioavailability and toxic side effects. The use of polymer carriers for anticancer drugs opens up new possibilities in cancer treatment by optimizing and vectorizing the pharmacological action, decreasing toxicity and increasing bioavailability of drugs [2][3][4][5]. The application of polymer nanoparticles, hydrogels [6], amphiphilic co-network gels [7][8][9][10] and other macromolecular systems [11,12] allows for a significant increasing in the bioavailability and a decreasing in the toxic effects of pharmacologically active drugs.…”

Lipid Nanoparticles: Promising Treatment Approach for Parkinson’s Disease

“…The principal use of NPs is to overcome challenges faced by commonly used drugs, such as poor stability, potential immunogenicity, solubility, and reduced plasma half-life [ 37 ]. Nanodelivery systems can increase the therapeutics circulation time, allow several different administration routes, circumvent potential solubility issues using hydrophobic molecules, and cater for favorable biodistribution of the therapeutic gene or drug [ 38 ].…”

Mobile Health Crowdsensing (MHCS) Intervention on Chronic Disease Awareness: Protocol for a Systematic Review

“…The key information to be extracted includes the following: author name(s) and year of the study, type of participant/study population and demographic characteristics; type of mHealth device used (eg, mobile phones, PDAs, smartphones, tablets); type of intervention (eg, SMS, MMS, video, text, audio); nature of the mHealth intervention (eg, awareness, diagnosis, treatment); type of study (eg, randomized, nonrandomized); type of outcome measured; and findings/results. Following Saidi et al's [32] procedure, data will be entered into Review Manager software, version 5.3. (Cochrane).…”

“…The extracted data will be presented in an evidence table adapted from Saidi et al's [32] study. A descriptive synthesis will be undertaken in accordance with the Centre for Reviews and Dissemination [35].…”